2023 updated MASCC/ESMO consensus recommendations: prevention of radiotherapy- and chemoradiotherapy-induced nausea and vomiting

Radiotherapy and chemoradiotherapy-induced nausea and vomiting (RINV and C-RINV) are common and distressing, and there is a need for guidance for clinicians to provide up to date optimal antiemetic prophylaxis and treatment. Through a comprehensive review of the literature concerning RINV and C-RINV...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ruhlmann, Christina H. (VerfasserIn) , Jordan, Karin (VerfasserIn) , Jahn, Franziska (VerfasserIn) , Maranzano, Ernesto (VerfasserIn) , Molassiotis, Alex (VerfasserIn) , Dennis, Kristopher (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 15 December 2023
In: Supportive care in cancer
Year: 2023, Jahrgang: 32, Heft: 1, Pages: 1-9
ISSN:1433-7339
DOI:10.1007/s00520-023-08226-z
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00520-023-08226-z
Volltext
Verfasserangaben:Christina H. Ruhlmann, Karin Jordan, Franziska Jahn, Ernesto Maranzano, Alex Molassiotis, Kristopher Dennis
Beschreibung
Zusammenfassung:Radiotherapy and chemoradiotherapy-induced nausea and vomiting (RINV and C-RINV) are common and distressing, and there is a need for guidance for clinicians to provide up to date optimal antiemetic prophylaxis and treatment. Through a comprehensive review of the literature concerning RINV and C-RINV, this manuscript aims to update the evidence for antiemetic prophylaxis and rescue therapy and provide a new edition of recommendations for the MASCC/ESMO antiemetic guidelines for RINV and C-RINV.
Beschreibung:Gesehen am 08.04.2024
Beschreibung:Online Resource
ISSN:1433-7339
DOI:10.1007/s00520-023-08226-z